Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia

Overview of attention for article published in BMC Infectious Diseases, January 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 28 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Georgia Hepatitis Elimination Program progress report 2020-2021

Cited by Centers for Disease Control and Prevention (CDC) on 20 Apr 2022

CDC is America’s leading public health agency, dedicated to saving and protecting the health of Americans. CDC monitors health, informs decisionmakers, and provides people with information so they can take responsibility for their own health.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.